CIK 0001095981 · Non-accelerated filer<br>Smaller reporting company
CERENOME, INC.
Sign in to watch- Ticker
- CNSY
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 330827593
- Phone
- 737.255.7194
- Business address
- 6420 LEVIT GREEN BOULEVARD, SUITE 310, HOUSTON, TX, 77021
- Former names
- PLUS THERAPEUTICS, INC., CYTORI THERAPEUTICS, INC., MACROPORE INC
- 4 Open-market buy Director bought 6,993 shares at $1.43 ($10,022)
- 4 Open-market buy Director bought 20,000 shares at $1.70 ($34,062)
- 424B3 Offering Prospectus
- EFFECT Other Notice of Effectiveness
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- S-1 Offering Registration Statement
- 4 Open-market buy Director bought 1,000 shares at $3.98 ($3,980)
- 8-K Event Other events
- 4 Open-market buy Director bought 2,500 shares at $3.64 ($9,102)
- 8-K Event Shareholder rights changed · Bylaws or fiscal year change · Shareholder vote results · Other events
- 8-K Event Shareholder vote results
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- 8-K Event Regulation FD disclosure
- DEF 14A Proxy Proxy Statement
- 4 Open-market buy Director bought 1 shares at $1,000.00 ($1,000)
- 8-K Event Material agreement · Unregistered share sale · Shareholder rights changed · Bylaws or fiscal year change
Page 13 of 74 · 1,465 filings